ArticleAnnals of gastroenterological surgery2026
To Evaluate Whether Pretreatment CA19-9 and DUPAN-2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer.
Hiromichi Kawaida et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.